We are live on ! Find out more
PL

Parkwood LLC Portfolio holdings

AUM $1.13B
1-Year Est. Return 32.89%
This Fund
S&P 500
This Quarter Est. Return
+7.68%
1 Year Est. Return
+32.89%
3 Year Est. Return
+85.78%
5 Year Est. Return
+92.19%
10 Year Est. Return
+373.76%
AUM
$862M
AUM Growth
+$297M
Cap. Flow
+$247M
Cap. Flow %
28.66%
Top 10 Hldgs %
52.61%
Holding
133
New
24
Increased
40
Reduced
40
Closed
14

Top Buys

Rank Stock Value
1
CNX icon
CNX Resources
CNX
+$7.28M
2
VT icon
Vanguard Total World Stock ETF
VT
+$6.79M
3
BAC icon
Bank of America
BAC
+$6.71M
4
VALE icon
Vale
VALE
+$6.36M
5
TIGO icon
Millicom
TIGO
+$4.92M

Sector Composition

Rank Sector Weight
1 Technology 11.34%
2 Financials 11.26%
3 Healthcare 10.1%
4 Communication Services 6.53%
5 Consumer Discretionary 3.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTON icon
101
Peloton Interactive
PTON
$2.77B
$654K 0.08%
5,274
+1,443
+38% +$154K
FMTX
102
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$625K 0.07%
25,128
+1,047
+4% +$28.1K
NKTX icon
103
Nkarta
NKTX
$150M
$590K 0.07%
18,618
-896
-5% -$25.8K
ACAD icon
104
Acadia Pharmaceuticals
ACAD
$4.43B
$571K 0.07%
23,417
-3,039
-11% -$68.6K
DCT
105
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
$548K 0.06%
12,603
+6,965
+124% +$283K
CARG icon
106
CarGurus
CARG
$3.27B
$516K 0.06%
19,675
+4,116
+26% +$107K
ITOS
107
DELISTED
iTeos Therapeutics
ITOS
$484K 0.06%
18,859
+6,608
+54% +$157K
IMGN
108
DELISTED
Immunogen Inc
IMGN
$428K 0.05%
+64,924
New +$453K
MGNX icon
109
MacroGenics
MGNX
$235M
$398K 0.05%
+14,803
New +$434K
NVTA
110
DELISTED
Invitae Corporation
NVTA
$349K 0.04%
10,340
+2,238
+28% +$72.8K
AR icon
111
Antero Resources
AR
$11.1B
$306K 0.04%
+20,371
New +$239K
ALXN
112
DELISTED
Alexion Pharmaceuticals
ALXN
$299K 0.03%
1,628
-3,472
-68% -$596K
BMRN icon
113
BioMarin Pharmaceuticals
BMRN
$11.6B
$288K 0.03%
3,448
-1,110
-24% -$88K
PAGP icon
114
Plains GP Holdings
PAGP
$5.21B
$132K 0.02%
11,019
-1,038
-9% -$11.1K
ET icon
115
Energy Transfer Partners
ET
$70.1B
$131K 0.02%
12,313
-1,881
-13% -$18K
ARVN icon
116
Arvinas
ARVN
$518M
-12,773
Closed -$844K
AVIR icon
117
Atea Pharmaceuticals
AVIR
$376M
-8,341
Closed -$515K
BIDU icon
118
Baidu
BIDU
$37.7B
-19,118
Closed -$4.16M
CMCSA icon
119
Comcast
CMCSA
$85B
-141,020
Closed -$7.63M
CNC icon
120
Centene
CNC
$30.7B
-58,801
Closed -$3.76M
CSGP icon
121
CoStar Group
CSGP
$11.7B
-17,930
Closed -$1.47M
GMAB icon
122
Genmab
GMAB
$17.7B
-128,955
Closed -$4.23M
MELI icon
123
Mercado Libre
MELI
$95.2B
-2,713
Closed -$3.99M
PRLD icon
124
Prelude Therapeutics
PRLD
$366M
-5,037
Closed -$218K
SNOW icon
125
Snowflake
SNOW
$102B
-33,652
Closed -$7.72M

Similar funds

Parkwood LLC's Q2 2021 Portfolio in Review

As of Q2 2021, Parkwood LLC held 133 positions worth $862M, up 52% from $566M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Parkwood LLC deployed $247M of net new capital in Q2 2021, opening 24 new positions and adding to 40 existing holdings. Its largest new stake was CNX Resources: 520,815 shares worth $7.11M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard Morningstar Total Stock Market ETF, an estimated $29.1M trimmed.

  • Parkwood LLC's largest Q2 2021 buy was CNX Resources: 520,815 shares worth $7.11M.
  • Parkwood LLC added most to Vanguard Total World Stock ETF in Q2 2021, an estimated $6.79M increase.
  • Parkwood LLC's biggest Q2 2021 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $29.1M.
  • Parkwood LLC fully exited Snowflake in Q2 2021, selling an estimated $7.72M.
  • Parkwood LLC's ten largest holdings make up 53% of its $862M portfolio in Q2 2021.
  • Parkwood LLC opened 24 new positions and closed 14 in Q2 2021.
  • Parkwood LLC's portfolio value rose 52% quarter-over-quarter to $862M.

Based on Parkwood LLC's 13F filing for Q2 2021, filed 13 Aug 2021.